Treatment with Dalcetrapib modifies the relationship between high-density lipoprotein cholesterol and C-reactive protein

Pitts, R. et al. (2016) Treatment with Dalcetrapib modifies the relationship between high-density lipoprotein cholesterol and C-reactive protein. Journal of the American College of Cardiology, 68(22), pp. 2488-2490. (doi:10.1016/j.jacc.2016.09.932) (PMID:27908356)

Full text not currently available from Enlighten.


Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Pitts, R., Gunzburger, E., Ballantyne, C. M., Barter, P. J., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J.V., Nicholls, S. J., Niesor, E. J., Olsson, A. G., Shah, P. K., Tardif, J.-C., Kittelson, J., and Schwartz, G. G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of the American College of Cardiology
Publisher:Elsevier
ISSN:0735-1097
Published Online:28 November 2016

University Staff: Request a correction | Enlighten Editors: Update this record